Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Three-year update of sildenafil citrate (viagra((R))) efficacy and safety
Autore:
Sadovsky, R; Miller, T; Moskowitz, M; Hackett, G;
Indirizzi:
SUNY Hlth Sci Ctr, Dept Family Practice, Brooklyn, NY 11203 USA SUNY Hlth Sci Ctr Brooklyn NY USA 11203 Practice, Brooklyn, NY 11203 USA Uniformed Serv Univ Hlth Sci, Dept Family Med, Bethesda, MD 20814 USA Uniformed Serv Univ Hlth Sci Bethesda MD USA 20814 Bethesda, MD 20814 USA Boston Univ, Sch Med, Sect Gen Internal Med, Boston, MA 02118 USA Boston Univ Boston MA USA 02118 ct Gen Internal Med, Boston, MA 02118 USA Good Hope Hosp, Sutton Coldfield, W Midlands, England Good Hope Hosp Sutton Coldfield W Midlands England , W Midlands, England
Titolo Testata:
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
fascicolo: 2, volume: 55, anno: 2001,
pagine: 115 - 128
SICI:
1368-5031(200103)55:2<115:TUOSC(>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
SPINAL-CORD INJURY; QUALITY-OF-LIFE; RADICAL RETROPUBIC PROSTATECTOMY; ERECTILE DYSFUNCTION; ORAL SILDENAFIL; CARDIOVASCULAR-DISEASE; SEXUAL DYSFUNCTION; MULTIPLE-SCLEROSIS; RANDOMIZED TRIAL; MEN;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
98
Recensione:
Indirizzi per estratti:
Indirizzo: Sadovsky, R SUNY Hlth Sci Ctr, Dept Family Med, Box 67,450 Clarkson Ave, Brooklyn, NY 11203 USA SUNY Hlth Sci Ctr Box 67,450 Clarkson Ave Brooklyn NYUSA 11203
Citazione:
R. Sadovsky et al., "Three-year update of sildenafil citrate (viagra((R))) efficacy and safety", INT J CL PR, 55(2), 2001, pp. 115-128

Abstract

In the three years since its launch, sildenafil citrate (Viagra (R)), an oral agent for the treatment of erectile dysfunction (ED), has been prescribed to more than 10 million patients worldwide and has been further evaluated in clinical studies in diverse patient populations. Significant improvements in erectile function have been demonstrated in double-blind, placebo-controlled trials in patients with ED and underlying diabetes, cardiovasculardisease, minor depression, spinal cord injury and multiple sclerosis, Promising results have also been reported for patients with treated prostate cancer, end-stage renal failure, Parkinson's disease, and spina bifida and inmultiple organ transplant recipients. Accounts of sildenafil use in clinical practice and postmarketing data reflect clinical trial findings of effectiveness in a broad spectrum of ED aetiologies and overall good tolerability. As in the clinical trials, most adverse events associated with sildenafil use have been transient, mild or moderate effects that rarely lead to treatment discontinuation.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/20 alle ore 07:39:20